US Stock MarketDetailed Quotes

ADAP Adaptimmune Therapeutics

Watchlist
  • 1.280
  • +0.040+3.23%
Close Jul 12 16:00 ET
  • 1.320
  • +0.040+3.13%
Post 19:54 ET
327.12MMarket Cap-1763P/E (TTM)

Adaptimmune Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q1
Stock NameRevenueRatio
Development revenue5.68M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United Kingdom (U.K.)60.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept CAR-T Therapy
CAR-T Therapy
Intraday+0.74%